Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model

por Sosne G, Ousler GW
Publicado 2015

Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy

por Gomes PJ, Ousler GW, Welch DL, Smith LM, Coderre J, Abelson MB
Publicado 2013

Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial

por Patane MA, Cohen A, From S, Torkildsen G, Welch D, Ousler GW 3rd
Publicado 2011

Safety and efficacy of MIM D3 ophthalmic solutions in a randomized placebo controlled Phase 2 clinical trial in patients with dry eye

por Meerovitch K, Torkildsen G, Lonsdale J, Goldfarb H, Lama T, Cumberlidge G, Ousler GW III
Publicado 2013

Blink patterns and lid-contact times in dry-eye and normal subjects

por Ousler GW 3rd, Abelson MB, Johnston PR, Rodriguez J, Lane K, Smith LM
Publicado 2014